Cercar
01/09/2024
Myocardial steatosis and improvement of cardiac function after glycaemic optimisation treatment in newly diagnosed type 2 diabetes subjects
Rosales, A, Gil, P, Julian, T, Teis, A, Pedraz, B, Sanchez, J, Julve, J, Mauricio, D, Perez, A, Alonso, N. Myocardial steatosis and improvement of cardiac function after glycaemic optimisation treatment in newly diagnosed type 2 diabetes subjects. DIABETOLOGIA. 2024; 67DOI:. PMID:. IF:10.200(Q1/1D).
01/08/2024
Effectiveness of a multicomponent healthcare intervention on blood pressure and lipids among subjects with poorly controlled type 2 diabetes: Findings from the INTEGRA study
Vlacho, B, Iniesta, AM, Gratacòs, M, Mata-Cases, M, Rubinat, E, Berenguera, A, Cos, FX, Franch-Nadal, J, Mauricio, D. Effectiveness of a multicomponent healthcare intervention on blood pressure and lipids among subjects with poorly controlled type 2 diabetes: Findings from the INTEGRA study. Primary Care Diabetes. 2024; 18(4)DOI:10.1016/j.pcd.2024.05.001. PMID:38782704. IF:2.300(Q2/5D).
01/08/2024
DECIPHERING THE EXTRACELLULAR EFFECTS OF SUCCINATE IN ATHEROSCLEROTIC DISEASE PROGRESSION: A TRANSLATIONAL APPROACH
Giné, LC, Caro-Pérez, P, Villanueva-Carmona, T, Rodríguez-Peña, MM, Núñez-Roa, C, Granado-Casas, M, Santos, D, Mauricio, D, Rotllan, N, Escola-Gil, JC, Vendrell, J, Fernández-Veledo, S. DECIPHERING THE EXTRACELLULAR EFFECTS OF SUCCINATE IN ATHEROSCLEROTIC DISEASE PROGRESSION: A TRANSLATIONAL APPROACH. ATHEROSCLEROSIS. 2024; 395DOI:. PMID:. IF:5.700(Q1/1D).
01/08/2024
Impact of the presence and type of cardiovascular disease on the risk of mortality in type 2 diabetic patients: The DIABET-IC trial
Orna, JAG, Martínez, ABM, Padial, LR, Sánchez, MA, Barrios, V, García, JM, Perez, AP. Impact of the presence and type of cardiovascular disease on the risk of mortality in type 2 diabetic patients: The DIABET-IC trial. Endocrinologia Diabetes y Nutricion. 2024; 71(7)DOI:10.1016/j.endien.2024.07.001. PMID:39095283. IF:1.800(Q3/8D).